Harry E. Carmitchel

VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA.

Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019.

Synthes Spine Co. offers implants and instruments for the treatment of fractures, tumors, deformities, and degenerative diseases affecting the spine. Its products include plates, screws, rods, cables, and hooks designed to stabilize the spine. Synthes Spine was founded in 1998 and is headquartered in West Chester, PA.

Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA.

General Electric Capital Corp. provides financial products and services. Its services include commercial loans and leases, fleet management, financial programs, credit cards, personal loans, and other financial services. The firm’s solutions include energy finance and aviation finance. The company was founded in 1943 and is headquartered in Norwalk, CT.

Part of GE Aerospace, GE Capital Business Processes Management Services Ltd. is an Indian company that provides back-office support to non-banking financial companies, banks, and other customers. The company is based in Gurgaon, India.

Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a company that manufactures surgical appliances. The company is based in Arlington, TX.

Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA.

Supportive Concepts For Families, Inc. provides supportive living services for families. Its programs include accessing services, intellectual disabilities, behavioral health and transportation. The company was founded in 1993 and is headquartered in Reading, PA.

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

Global Healthcare Exchange LLC engages in the provision of supply chain automation services for the healthcare sector. It offers E-commerce; Contracting; AP Automation; Data Management; Business Intelligence; and Compliance and Credentialing solutions. The company was founded in 2000 and is headquartered in Louisville, CO.

Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies

Kosmo Technologies, Inc. engages in the research and development of products for doctors in the field of Dental Sleep, Functional Orthodontics, Orthodontics, TMD, neuromuscular Dentistry and Sleep Medicine. Its products include Andra Gauge and Airway Optomizer. The company is headquartered in Salt Lake City, UT.

Maryland Venture (Maryland Venture) is a venture capital subsidiary of Maryland Technology Development Corporation (TEDCO) founded in 1994. The firm is headquartered in Columbia, Maryland.

Consumer Sleep Solutions LLC develops and operates electronic device which provides sleep score through mobile application. The company was founded by Mehmet C. Oz on November 9, 2016 and is headquartered in Carlsbad, CA.

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation.